In 2020, Cheryl R. Blanchard earned $1.29M in total compensation at Anika Therapeutics, including $625.00K salary, $331.01K bonus and $303.64K in stock. Most recently acquired 8,100 shares in Mar 2022. Currently holds stock worth $2.06M.
Compensation History
Annual executive compensation data for Cheryl R. Blanchard, including salary, bonuses, and stock awards.
Year
2020
Total Compensation
$1.29M
Salary
$625.00K
Bonus
$331.01K
Other
$27.96K
Salary
$625.00KBoard Justification
The compensation philosophy is designed to drive long-term high performance and increase stockholder value through competitive compensation packages that align with company performance and individual contributions.
Bonus
$331.01KBoard Justification
This amount reflects the discretionary prorated cash bonus earned for the indicated year of $331,010 and a cash retention bonus of $127,500 provided under the terms of the interim Chief Executive Officer letter agreement entered into between the company and Dr. Blanchard.
Other Compensation
$27.96KBoard Justification
This amount includes matching contributions to the 401(k) Plan and group term life insurance premiums.
Restricted Stock
Board Justification
This amount includes 3,842 restricted stock units granted to Dr. Blanchard as an independent director on February 26, 2019 that vested in 2020.
Performance Metrics
The performance metrics include revenue growth, adjusted EBITDA, and individual performance contributions.
Cheryl R. Blanchard
Ex-CEO of Anika Therapeutics
Sector of Economy
Healthcare
CEO of Anika Therapeutics for
0 years 4 months (Feb 2020 - Jun 2020)
Previous Experience
Unknown
Holdings
Track Cheryl R. Blanchard's stock holdings and portfolio value over time.
Insider Trading
Cheryl R. Blanchard's recent stock transactions, purchases, and sales filed with the SEC.
$207.25K
ANIK at $25.59/share
Mar 11, 2022
Purchase
3,842 shares
ANIK
Feb 26, 2019
Received
3,624 shares
ANIK
Aug 31, 2018
Received
Rivals
Compare Cheryl R. Blanchard with competitor CEOs and industry peers.